Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Surg ; 196(6): 883-9; discussion 889, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19095104

RESUMO

BACKGROUND: We hypothesized that implementing a quality care initiative, including peri-incisional antibiotic administration, tight blood glucose control, and hair removal with clippers would reduce surgical site infection (SSI) rates in patients undergoing coronary artery bypass grafting (CABG), with or without valve replacement. METHODS: Patients undergoing CABG were studied retrospectively, before (n = 808) and after (n = 674) instituting a patient care protocol. The pathway included peri-incisional antibiotics, tight glucose control (80 mg/dL-110 mg/dL) throughout intensive care unit (ICU) stays, and hair removal with clippers. RESULTS: SSIs were significantly decreased in the experimental group (1.5%), compared with the control group (3.5%), (P = .001, odds ratio [OR] = .21). Significant independent predictors of infection included diabetes mellitus (P = .001, OR = 4.71), Nosocomial Infection Surveillance System (NNIS) wound class II (P = .044, OR = 2.07), and female gender (P = .001, OR = 2.83). CONCLUSIONS: Protocols implementing timely perioperative antibiotics, tight blood glucose control, and avoidance of shaving decrease SSI rates in CABG patients.


Assuntos
Antibioticoprofilaxia/métodos , Ponte de Artéria Coronária , Assistência ao Paciente/normas , Garantia da Qualidade dos Cuidados de Saúde , Infecção da Ferida Cirúrgica/epidemiologia , Infecção da Ferida Cirúrgica/prevenção & controle , Idoso , Antibioticoprofilaxia/normas , Glicemia/metabolismo , Doença das Coronárias/cirurgia , Feminino , Humanos , Incidência , Masculino , Cuidados Pré-Operatórios/métodos , Estudos Retrospectivos , Fatores de Risco , Infecção da Ferida Cirúrgica/sangue , Taxa de Sobrevida/tendências , Estados Unidos/epidemiologia
2.
Am J Obstet Gynecol ; 195(5): 1398-403, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16723106

RESUMO

OBJECTIVE: We hypothesized that cardiac function would be reduced in a pregnant rat model of preeclampsia induced by L-NAME, a NOS inhibitor, and be reversed with magnesium sulfate prophylaxis. STUDY DESIGN: Female Sprague-Dawley rats were bred in-house. On gestational day 17, rats were anesthetized and osmotic minipumps were implanted to continuously deliver saline, L-NAME, or L-NAME and MgSO4. On gestational day 21, hearts were isolated and perfused in the working mode using Krebs Henseleit buffer. RESULTS: Pregnant rats treated with L-NAME displayed significant hypertension compared to the saline-treated controls (P < 0.05). Moreover, cardiac output and cardiac work were significantly reduced in the L-NAME-treated rats compared to controls (P < 0.05). In the L-NAME-treated rats given MgSO4, cardiac function remained normal. CONCLUSION: Cardiac function is depressed in an animal model of preeclampsia induced by L-NAME infusion. MgSO4 prevented the reduction in cardiac function and is clearly beneficial in preserving normal heart function in preeclampsia.


Assuntos
Sulfato de Magnésio/uso terapêutico , Pré-Eclâmpsia/tratamento farmacológico , Disfunção Ventricular Esquerda/prevenção & controle , Animais , Débito Cardíaco , Modelos Animais de Doenças , Inibidores Enzimáticos , Feminino , Coração/efeitos dos fármacos , Coração/fisiopatologia , Hipertensão/fisiopatologia , NG-Nitroarginina Metil Éster , Pré-Eclâmpsia/induzido quimicamente , Pré-Eclâmpsia/fisiopatologia , Gravidez , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...